Can HIV infection be prevented with a once-daily pill?
Nearly four years after political pressure shut down two trials that would have tested whether a once-a-day pill could prevent high-risk HIV-negative people from catching the AIDS-causing virus, there’s a surge of renewed interest in the concept, known as Pre-Exposure Prophylaxis, or PrEP.
December 1, 2008 — Scientific American
Circumcision clinic has African men lining up to prevent AIDS
Since a study by Bailey in 2006 found the operation drops the HIV infection rate in men by 60 percent, the procedure most often performed at birth has become a popular elective surgery among grown men in southern Africa.
July 31, 2008 — Bloomberg
HIV vaccine trial cancelled
The trial, called PAVE 100, would have tested whether a vaccine could help control HIV infection. The vaccine regimen was developed by the NIAID’s Vaccine Research Center and comprised a DNA vaccine containing HIV genes, with a modified cold virus carrying HIV genes as a booster.
July 18, 2008 — Nature
US scraps plan to test AIDS vaccine
The US National Institutes of Health scrubbed plans to test its AIDS vaccine due to concerns about its safety and effectiveness, 10 months after the collapse of a clinical trial for a similar vaccine from Merck & Co.
July 18, 2008 — Wall Street Journal